2021. Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus . Academia Journal of Medicine. 4, 2 (Dec. 2021), 50–54. DOI:https://doi.org/10.48165/3e51d373.